292 related articles for article (PubMed ID: 10069545)
1. Effects of naltrexone on alcohol self-administration in heavy drinkers.
Davidson D; Palfai T; Bird C; Swift R
Alcohol Clin Exp Res; 1999 Feb; 23(2):195-203. PubMed ID: 10069545
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
[TBL] [Abstract][Full Text] [Related]
4. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
McCaul ME; Wand GS; Rohde C; Lee SM
Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
[TBL] [Abstract][Full Text] [Related]
5. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
6. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
Galloway GP; Koch M; Cello R; Smith DE
BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
[TBL] [Abstract][Full Text] [Related]
11. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ
J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
[TBL] [Abstract][Full Text] [Related]
12. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.
Kranzler HR; Armeli S; Feinn R; Tennen H
J Consult Clin Psychol; 2004 Apr; 72(2):317-27. PubMed ID: 15065964
[TBL] [Abstract][Full Text] [Related]
13. Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.
Krishnan-Sarin S; O'Malley SS; Franco N; Cavallo DA; Tetrault JM; Shi J; Gueorguieva R; Pittman B; Krystal JH
Neuropsychopharmacology; 2020 Jan; 45(2):319-326. PubMed ID: 31590179
[TBL] [Abstract][Full Text] [Related]
14. Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies.
Palfai T; Davidson D; Swift R
Exp Clin Psychopharmacol; 1999 Aug; 7(3):266-73. PubMed ID: 10472515
[TBL] [Abstract][Full Text] [Related]
15. Biphasic alcohol response differs in heavy versus light drinkers.
King AC; Houle T; de Wit H; Holdstock L; Schuster A
Alcohol Clin Exp Res; 2002 Jun; 26(6):827-35. PubMed ID: 12068251
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.
King AC; Volpicelli JR; Gunduz M; O'Brien CP; Kreek MJ
Alcohol Clin Exp Res; 1997 Aug; 21(5):906-9. PubMed ID: 9267542
[TBL] [Abstract][Full Text] [Related]
17. Alcohol consumption is enhanced after naltrexone treatment.
Juárez J; Eliana Bde T
Alcohol Clin Exp Res; 2007 Feb; 31(2):260-4. PubMed ID: 17250617
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone increases the latency to drink alcohol in social drinkers.
Davidson D; Swift R; Fitz E
Alcohol Clin Exp Res; 1996 Jun; 20(4):732-9. PubMed ID: 8800392
[TBL] [Abstract][Full Text] [Related]
20. The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers.
Armeli S; Feinn R; Tennen H; Kranzler HR
Exp Clin Psychopharmacol; 2006 May; 14(2):199-208. PubMed ID: 16756424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]